AI-Based Early Detection and Subtyping of Non-Small Cell Lung Cancer from Blood Samples Using Orphan Non-Coding RNAs
Our findings demonstrate highly sensitive and specific detection of the earliest non-small cell lung tumors using Exai’s novel RNA- and AI-based liquid biopsy platform.
